TY - JOUR
T1 - Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy
T2 - comparable survival-outcomes in upper tract urothelial carcinoma
AU - Tsujino, Takuya
AU - Komura, Kazumasa
AU - Inamoto, Teruo
AU - Maenosono, Ryoichi
AU - Hashimoto, Takeshi
AU - Adachi, Takahiro
AU - Hirasawa, Yosuke
AU - Tokushige, Satoshi
AU - Ohno, Takaya
AU - Yamazaki, Shogo
AU - Fukushima, Tatsuo
AU - Nakamura, Ko
AU - Yano, Yusuke
AU - Nishimura, Kazuki
AU - Kinoshita, Shoko
AU - Nakamori, Keita
AU - Tsutsumi, Takeshi
AU - Matsunaga, Tomohisa
AU - Yoshikawa, Yuki
AU - Uchimoto, Taizo
AU - Takai, Tomoaki
AU - Minami, Koichiro
AU - Uehara, Hirofumi
AU - Hirano, Hajime
AU - Nomi, Hayahito
AU - Takahara, Kiyoshi
AU - Ohno, Yoshio
AU - Azuma, Haruhito
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2023/12
Y1 - 2023/12
N2 - Purpose: This study investigates the utility of ureteroscopic surgery (URS) as an alternative to radical nephroureterectomy (RNU) in managing upper tract urothelial carcinoma (UTUC), with a focus on survival outcomes and re-evaluation of current the European Association of Urology guidelines criteria. Methods: We conducted a retrospective, multi-institutional review of 143 UTUC patients treated with URS (n = 35) or RNU (n = 108). Clinicopathological factors were analyzed, and survival outcomes were assessed using Kaplan–Meier analysis and Cox proportional-hazards models. Results: The median follow-up period was 27 months. Overall survival (OS) and radiographic progression-free survival (rPFS) were comparable between the URS and RNU groups (OS: HR 2.42, 95% CI 0.63–9.28, P = 0.0579; rPFS: HR 1.82, 95% CI 0.60–5.47, P = 0.1641). URS conferred superior renal function preservation. In patients characterized by factors such as radiographically invisible lesions, negative cytology, pTa stage, low-grade tumors, and multiple lesions, the OS outcomes with URS were comparable to those with RNU as follows: radiographically invisible lesions (P = 0.5768), negative cytology (P = 0.7626), pTa stage (P = 0.6694), low-grade tumors (P = 0.9870), and multiple lesions (P = 0.8586). Conclusion: URS offers survival outcomes similar to RNU, along with better renal function preservation, especially in low-risk UTUC patients. These findings underscore the urgency of re-evaluating the current EAU guidelines and encourage further research into determining the ideal patient selection for URS in UTUC treatment.
AB - Purpose: This study investigates the utility of ureteroscopic surgery (URS) as an alternative to radical nephroureterectomy (RNU) in managing upper tract urothelial carcinoma (UTUC), with a focus on survival outcomes and re-evaluation of current the European Association of Urology guidelines criteria. Methods: We conducted a retrospective, multi-institutional review of 143 UTUC patients treated with URS (n = 35) or RNU (n = 108). Clinicopathological factors were analyzed, and survival outcomes were assessed using Kaplan–Meier analysis and Cox proportional-hazards models. Results: The median follow-up period was 27 months. Overall survival (OS) and radiographic progression-free survival (rPFS) were comparable between the URS and RNU groups (OS: HR 2.42, 95% CI 0.63–9.28, P = 0.0579; rPFS: HR 1.82, 95% CI 0.60–5.47, P = 0.1641). URS conferred superior renal function preservation. In patients characterized by factors such as radiographically invisible lesions, negative cytology, pTa stage, low-grade tumors, and multiple lesions, the OS outcomes with URS were comparable to those with RNU as follows: radiographically invisible lesions (P = 0.5768), negative cytology (P = 0.7626), pTa stage (P = 0.6694), low-grade tumors (P = 0.9870), and multiple lesions (P = 0.8586). Conclusion: URS offers survival outcomes similar to RNU, along with better renal function preservation, especially in low-risk UTUC patients. These findings underscore the urgency of re-evaluating the current EAU guidelines and encourage further research into determining the ideal patient selection for URS in UTUC treatment.
UR - http://www.scopus.com/inward/record.url?scp=85175719826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85175719826&partnerID=8YFLogxK
U2 - 10.1007/s00345-023-04687-3
DO - 10.1007/s00345-023-04687-3
M3 - Article
C2 - 37924336
AN - SCOPUS:85175719826
SN - 0724-4983
VL - 41
SP - 3585
EP - 3591
JO - World Journal of Urology
JF - World Journal of Urology
IS - 12
ER -